Abbott Laboratories (ABT) Stock Valuation: P/E Ratio and Intrinsic Value
Is Abbott Laboratories stock expensive or cheap? This page shows the price-earnings ratio of Abbott Laboratories for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings (FY 2025).
Earnings basis for the valuation (FY 2025)
| Revenue | 44.33 USD bn |
|---|---|
| Net income | 6.74 USD bn |
| Net margin | 15.2 % |
How the Abbott Laboratories P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Abbott Laboratories is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Abbott Laboratories
What is the ABT P/E ratio?
The P/E ratio divides the Abbott Laboratories share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of ABT can be compared with its own history.
Is Abbott Laboratories stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of ABT is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Abbott Laboratories?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of ABT as the starting point.